Alembic Pharmaceuticals share price rose 2 percent in the opening trade on November 17 following the company received final approval from USFDA for angina drug. At 09:19am, Alembic Pharmaceuticals was ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Ola Electric on Sunday said it has commenced test rides of its 4680 Bharat Cell vehicles at the company’s flagship stores across India. The S1 Pro+ (5.2 kWh) is the first product to be powered by the ...

Alembic Pharmaceuticals said on November 15 that it has secured final approval from the US Food and Drug Administration. The approval is granted for one of its important generic filings. The approval ...

Alembic Pharmaceuticals just got USFDA approval for its Diltiazem Hydrochloride Tablets—used to manage high blood pressure and chest pain. The approved tablets come in four strengths (30mg, 60mg, 90mg ...

Pharma major Alembic Pharmaceuticals on Saturday, November 15, announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application ...

Alembic Pharmaceuticals has received final approval from the USFDA for its Abbreviated New Drug Application for Diltiazem Hydrochloride Tablets USP in 30 mg, 60 mg, 90 mg and 120 mg strengths. The ...

Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...

Generic drugmaker Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for Diltiazem Hydrochloride tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg. A ...

Zydus Lifesciences Limited, along with its subsidiaries and affiliates (collectively referred to as “Zydus”), has secured final approval from the United States Food and Drug Administration (USFDA) for ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (FDA) for diltiazem hydrochloride tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg (USRLD: ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.